| Using Thoracic Ultrasound to Detect Interstitial Lung Disease in Patients With Rheumatoid Arthritis (NCT05396469) | Torkell Ellingsen | 2022-06-10 |
| Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 (NCT06383819) | NPO Petrovax | 2022-04-08 |
| A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) (NCT05285982) | Boehringer Ingelheim | 2022-04-06 |
| A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis (NCT05065190) | Boehringer Ingelheim | 2021-11-25 |
| BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease (NCT04930666) | Columbia University | 2021-11-10 |
| Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases (NCT04119115) | Corewell Health East | 2021-09-30 |
| Functional Exercise Tests in Patients With Systemic Sclerosis (NCT04650659) | University of Aarhus | 2021-07-27 |
| Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) (NCT04283994) | University of Washington | 2021-07-26 |
| INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation (NCT04702893) | Boehringer Ingelheim | 2021-05-28 |
| Database for Interstitial Lung Disease (NCT04707781) | Medical University of Graz | 2021-05-01 |
| Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest (NCT04170062) | Johns Hopkins University | 2020-12-15 |
| Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan (NCT04559581) | Boehringer Ingelheim | 2020-10-02 |
| Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound (NCT04195789) | Hospices Civils de Lyon | 2020-08-04 |
| Capnography Monitoring in Ventilated Children (NCT04354220) | Vincenzo Cannizzaro | 2020-06-09 |
| Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan (NCT04325217) | Boehringer Ingelheim | 2020-05-27 |
| Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) (NCT04281784) | University of Washington | 2020-04-23 |
| A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC (NCT04807114) | Universitaire Ziekenhuizen KU Leuven | 2020-02-01 |
| A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD) (NCT04093024) | Boehringer Ingelheim | 2019-12-03 |
| A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) (NCT03820726) | Boehringer Ingelheim | 2019-04-16 |
| Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD). (NCT04100226) | Cairo University | 2019-03-01 |
| Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise (NCT03718780) | Centre Hospitalier Metropole Savoie | 2019-02-22 |
| High Flow in Interstitial Lung Disease (NCT03816722) | Aalborg University Hospital | 2019-02-15 |
| Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease (NCT04630743) | University of Cologne | 2019-02-09 |
| BPF Genetics of ILD Study (NCT03747627) | University of Dundee | 2019-01-19 |
| Research of Burden of Interstititial Lung Diseases in Turkey (NCT03995654) | Karadeniz Technical University | 2019-01-01 |
| Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis (NCT03561818) | Istanbul Medipol University Hospital | 2018-06-19 |
| Interstitial Lung Disease (ILD). Diagnostic Yield of Surgical Lung Biopsy Versus Cryobiopsy in the Same Surgical Stage. (NCT03596528) | Hospital Clinic of Barcelona | 2018-03-23 |
| Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease (NCT03136120) | GlaxoSmithKline | 2017-11-21 |
| A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis (NCT03142191) | Celgene | 2017-07-26 |
| A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease (NCT03099187) | Hoffmann-La Roche | 2017-05-15 |
| Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) (NCT02999178) | Boehringer Ingelheim | 2017-01-17 |
| Hepatitis C Virus(HCV) Heart and Lung Study (NCT02858180) | Duke University | 2016-12-01 |
| Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis (NCT02705144) | Sheba Medical Center | 2016-03-01 |
| Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis (NCT02370693) | Northwestern University | 2016-03-01 |
| Computed Tomography Assessment of Regional Ventilation (CURVE) (NCT02879773) | Heart of England NHS Trust | 2016-01-22 |
| The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease (NCT02501668) | Keimyung University Dongsan Medical Center | 2015-07-01 |
| Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study (NCT02377739) | Schön Klinik Berchtesgadener Land | 2015-02-01 |
| Identification of Novel Markers of Human Lung Disease (NCT02369575) | Ohio State University | 2015-02-01 |
| Idiopathic Pulmonary Fibrosis and Serum Bank (NCT04016168) | Rennes University Hospital | 2014-10-22 |
| MSC for Treatment of Interstitial Lung Disease After Allo-HSCT (NCT02543073) | Nanfang Hospital, Southern Medical University | 2014-09-01 |
| Rituximab in Interstitial Pneumonitis (NCT02251964) | Human Adams | 2014-09-01 |
| Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients (NCT02125916) | University of Aarhus | 2014-07-01 |
| Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study (NCT02464592) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2014-04-01 |
| A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma (NCT01553981) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2012-03-01 |
| Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant (NCT01432080) | Maisonneuve-Rosemont Hospital | 2011-09-01 |
| Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications (NCT01374542) | Singapore General Hospital | 2011-06-01 |
| A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) (NCT01203943) | Celgene | 2011-01-01 |
| Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection (NCT00841750) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2008-07-01 |
| Epidemiology of Surfactant Protein-B Deficiency (NCT00014859) | Washington University School of Medicine | 2001-06-01 |
| Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis (NCT01442779) | Texas Tech University Health Sciences Center | 2000-09-01 |
| Linkage Study in Familial Pulmonary Fibrosis (NCT00016627) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-08-01 |
| Idiopathic Pulmonary Fibrosis: a Case-control Study (NCT00005295) | University of New Mexico | 1989-07-01 |
| Epidemiology of Interstitial Lung Disease (NCT00005290) | University of New Mexico | 1988-04-01 |
| Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases (NCT00005317) | National Heart, Lung, and Blood Institute (NHLBI) | 1986-12-01 |
| Popcorn Lung: the Discovery of a New Disease (NCT00027235) | National Center for Research Resources (NCRR) | |
| An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options (NCT04739150) | Boehringer Ingelheim | |